These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1522442)

  • 1. PDA response. FDA proposal to amend cGMP's entitled--use of aseptic processing and terminal sterilization in the preparation of sterile pharmaceuticals for human and veterinary use. Parenteral Drug Association.
    J Parenter Sci Technol; 1992; 46(3):65-8. PubMed ID: 1522442
    [No Abstract]   [Full Text] [Related]  

  • 2. An FDA update on GMP's for aseptic processing.
    Fry EM
    J Parenter Sci Technol; 1985; 39(4):154-7. PubMed ID: 3928863
    [No Abstract]   [Full Text] [Related]  

  • 3. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 4. Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice.
    Fed Regist; 1998 Jan; 63(18):4272-3. PubMed ID: 10177326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral Drug Association response to FDA proposal to prohibit the use of any antimicrobial preservative in single-dose parenteral drug products.
    J Parenter Sci Technol; 1985; 39(6):231-2. PubMed ID: 4093824
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
    J Parenter Sci Technol; 1988; 42(4):105. PubMed ID: 3183862
    [No Abstract]   [Full Text] [Related]  

  • 7. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 9. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
    J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
    [No Abstract]   [Full Text] [Related]  

  • 10. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing".
    Akers JE; Agalloco JP; Carleton FJ; Korczynski MS
    J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA update on aseptic processing guidelines.
    Fry EM
    J Parenter Sci Technol; 1987; 41(2):56-60. PubMed ID: 3598820
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the U.S. FDA Guideline on Aseptic Processing.
    Agalloco J
    J Parenter Sci Technol; 1992; 46(3):78-84. PubMed ID: 1522445
    [No Abstract]   [Full Text] [Related]  

  • 13. Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 May; 65(103):34082-9. PubMed ID: 11010719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory issues of parenteral equipment and systems.
    Avallone H
    J Parenter Sci Technol; 1988; 42(3):89-93. PubMed ID: 3216268
    [No Abstract]   [Full Text] [Related]  

  • 15. Good manufacturing practices and clinical supplies.
    Levchuk JW
    J Parenter Sci Technol; 1991; 45(3):152-5. PubMed ID: 1886044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological technical amendment--FDA. Final rule; technical amendment.
    Fed Regist; 1992 Apr; 57(64):11263. PubMed ID: 10118456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities.
    Mann CJ
    J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.